Kauvery Hospital in Chennai kick starts the antibody cocktail treatment for COVID-19 cancer patient at high risk of serious complications with mild symptoms through intravenous or subcutaneous (under the skin) route as an infusion or injection.
‘Tamil Nadu’s first SARS-CoV-2 antibody cocktail treatment for COVID-19 begins at Kauvery Hospital.’
Prof Dr Anita Ramesh, Senior Consultant, Medical Oncology, Kauvery Hospital Chennai, said, “The antibody cocktail drug is a combination of Casirivimab and Imdevimab, two antibodies which are lab-engineered, and created, proteins that will imitate the immune system’s ability to fight against this harmful pathogen. Given to those patients who are in their early stage of COVID-19 with mild symptoms, this will help reduce the multiplication of the virus, thus avoiding severe disease and hospitalization”.
This combination of two antibodies Casirivimab and imdevimab produced by Switzerland-based Roche fights against the coronavirus are specifically directed against the spike protein of SARS-CoV-2 by blocking the virus entry into human cells prevent the need for hospitalization.
Source: Medindia
